VISTA-16 Trial Site

Vascular Inflmation Suppression to Treat Acute Coronary Syndrome for 16 weeks...read more

PEARL-SC Trial Site

Phase 2b Study to Evaluate the Efficacy, Safety, & Tolerability of A-623 AdministRation in Subjects with Systemic Lupus Erythematosus...read more

FRANCIS Trial Site

Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression...read more

IMPACTS Trial Site

Investigation of the Modulation of Phospholipase in Acute ChesT Syndrome...read more